FBXO11 and acute myeloid leukemia: To assess whether this alternative splicing event occurs upon FBXO11 loss, we compared the frequency of EZH2 exon inclusion in SRSF2WT patient secondary AML samples stratified by FBXO11 expression (Fig. 4d, left panel).